239 related articles for article (PubMed ID: 38275068)
1. Nuchal Translucency and Congenital Heart Defects.
Sofia-Gonçalves A; Guedes-Martins L
Curr Cardiol Rev; 2024; 20(2):1-13. PubMed ID: 38275068
[TBL] [Abstract][Full Text] [Related]
2. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
3. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.
Bahado-Singh RO; Wapner R; Thom E; Zachary J; Platt L; Mahoney MJ; Johnson A; Silver RK; Pergament E; Filkins K; Hogge WA; Wilson RD; Jackson LG;
Am J Obstet Gynecol; 2005 May; 192(5):1357-61. PubMed ID: 15902108
[TBL] [Abstract][Full Text] [Related]
4. Risk of critical congenital heart defects by nuchal translucency norms.
Jelliffe-Pawlowski LL; Norton ME; Shaw GM; Baer RJ; Flessel MC; Goldman S; Currier RJ
Am J Obstet Gynecol; 2015 Apr; 212(4):518.e1-10. PubMed ID: 25448520
[TBL] [Abstract][Full Text] [Related]
5. [Birth defects associated with increased nuchal translucency].
Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
[TBL] [Abstract][Full Text] [Related]
6. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
[TBL] [Abstract][Full Text] [Related]
7. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
8. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
[TBL] [Abstract][Full Text] [Related]
9. Nuchal translucency and the risk of congenital heart disease.
Simpson LL; Malone FD; Bianchi DW; Ball RH; Nyberg DA; Comstock CH; Saade G; Eddleman K; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; D'Alton ME
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):376-83. PubMed ID: 17267839
[TBL] [Abstract][Full Text] [Related]
10. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
[TBL] [Abstract][Full Text] [Related]
11. Nuchal translucency in normal fetus and its variation with increasing crown rump length (CRL) and gestational age.
Karki S; Joshi KS; Tamrakar SR; Regmi S; Khanal K
Kathmandu Univ Med J (KUMJ); 2013; 11(44):282-6. PubMed ID: 24899320
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
Minnella GP; Crupano FM; Syngelaki A; Zidere V; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 May; 55(5):637-644. PubMed ID: 31875326
[TBL] [Abstract][Full Text] [Related]
13. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses.
Westin M; Saltvedt S; Bergman G; Almström H; Grunewald C; Valentin L
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):632-9. PubMed ID: 16715530
[TBL] [Abstract][Full Text] [Related]
14. [Increased nuchal translucency at 11-14 weeks of gestation in congenital heart disease, genetic syndromes and adverse pregnancy outcome].
Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Loquet P
Akush Ginekol (Sofiia); 2005; 44(6):8-15. PubMed ID: 18982826
[TBL] [Abstract][Full Text] [Related]
15. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
16. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis.
Makrydimas G; Sotiriadis A; Ioannidis JP
Am J Obstet Gynecol; 2003 Nov; 189(5):1330-5. PubMed ID: 14634564
[TBL] [Abstract][Full Text] [Related]
17. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
[TBL] [Abstract][Full Text] [Related]
18. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and outcome of increased nuchal translucency in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria: A cohort study.
Sulaiman B; Shehu CE; Panti AA; Saidu SA; Onankpa B; Ekele BA
Niger J Clin Pract; 2020 Jun; 23(6):864-869. PubMed ID: 32525124
[TBL] [Abstract][Full Text] [Related]
20. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
